Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Transportation × Thoracic × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 196 pembrolizumab 173 Pemetrexed 145 Cisplatin 119 Paclitaxel 83 durvalumab 77 Nivolumab 69 atezolizumab 67 Specimen Handling 66 osimertinib 57 Docetaxel 54 Magnetic Resonance Spectroscopy 50 Gemcitabine 42 Radiosurgery 36 Radiotherapy 35 Etoposide 32 cemiplimab 31 Drug Therapy 30 130-nm albumin-bound paclitaxel 30 Ipilimumab 29 Bevacizumab 29 Immunoglobulin G 21 Cetuximab 21 Biopsy 21 Taxes 20 Disulfides 20 tislelizumab 18 amivantamab 18 Platinum 18 Standard of Care 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06628167 2026-03-24

LCS II

Abramson Cancer Center at Penn Medicine

Phase NA Completed

252 enrolled 7 charts

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡